[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338086-105":59,"doc-detail-338086-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","leveraging-altered-lipid-metabolism-in-treating-b-cell-malignancies","Leveraging altered lipid metabolism in treating B cell malignancies","","B cell malignancies, comprising over 80 heterogeneous blood cancers, pose significant prognostic challenges due to intricate oncogenic signaling. Emerging evidence emphasizes the pivotal role of disrupted lipid metabolism in the development of these malignancies. Variations in lipid species, including phospholipids, cholesterol, sphingolipids, and fatty acids, are widespread across B cell malignancies, contributing to uncontrolled cell proliferation and survival and sustaining malignant behavior through altered signaling.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/leveraging-altered-lipid-metabolism-in-treating-b-cell-malignancies/338086/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/leveraging-altered-lipid-metabolism-in-treating-b-cell-malignancies/338086.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is altered lipid metabolism relevant to B cell malignancies?","Question",{"text":112,"@type":113},"Disrupted lipid metabolism contributes to development and progression of B cell malignancies by affecting lipid species that support proliferation and survival pathways.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do phospholipids influence malignant transformation in B cell cancers?",{"text":117,"@type":113},"Phospholipids participate in initial signaling cascades that enable B cell activation and malignant transformation through constitutive B cell receptor (BCR) signaling.",{"name":119,"@type":110,"acceptedAnswer":120},"What roles do cholesterol and sphingolipids play in oncogenic signaling?",{"text":121,"@type":113},"Dysregulated cholesterol and sphingolipid homeostasis support lipid raft integrity, which is crucial for propagating oncogenic signals.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338086,1790196861,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":31,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":24,"preview_urls":145},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Author Manuscript Author Manuscript Author Manuscript Author Manuscript  \n\n| | HHS Public Access\u003Cbr>Author manuscript\u003Cbr>Prog Lipid Res. Author manuscript; available in PMC 2024 August 27. |\n| --- | --- |\n\nPublished in final edited form as:  \nProg Lipid Res. 2024 July ; 95: 101288. doi:10.1016/j.plipres.2024.101288 .  \nLeveraging altered lipid metabolism in treating B cell malignancies  \nJaewoong Leea,b,c,d,* , Arya Manie,f, Min-Jeong Shina,b,c, Ronald M. Kraussg,**  \naSchool of Biosystems and Biomedical Sciences, College of Health Science, Korea University, Seoul 02841, Republic of Korea  \nb Department of Integrated Biomedical and Life Science, Korea University, Seoul 02841, Republic of Korea  \nc Interdisciplinary Program in Precision Public Health, Korea University, Seoul 02841, Republic of Korea  \ndCenter of Molecular and Cellular Oncology, Yale University, New Haven, CT 06511, USA e Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University, New Haven, CT 06511, USA  \nfDepartment of Genetics, Yale University, New Haven, CT 06511, USA  \ng Department of Pediatrics and Medicine, University of California San Francisco, San Francisco, CA 94143, USA  \nAbstract  \nB cell malignancies, comprising over 80 heterogeneous blood cancers, pose significant prognostic challenges due to intricate oncogenic signaling. Emerging evidence emphasizes the pivotal role of disrupted lipid metabolism in the development of these malignancies. Variations in lipid species, such as phospholipids, cholesterol, sphingolipids, and fatty acids, are widespread across B cell malignancies, contributing to uncontrolled cell proliferation and survival.  \nPhospholipids play a crucial role in initial signaling cascades leading to B cell activation and malignant transformation through constitutive B cell receptor (BCR) signaling. Dysregulated cholesterol and sphingolipid homeostasis support lipid raft integrity, crucial for propagating oncogenic signals. Sphingolipids impact malignant B cell stemness, proliferation, and survival, while glycosphingolipids in lipid rafts modulate BCR activation. Additionally, cancer cells  \nThis is an open access article under the CC BY-NC license ([http://creativecommons.org/licenses/by-nc/4.0/](http://creativecommons.org/licenses/by-nc/4.0/)).  \n*Corresponding author at: School of Biosystems and Biomedical Sciences, College of Health Science, Korea University, Seoul 02841, [Republic of Korea. jaewoong.lee.jl3663@yale.edu](Republic of Korea. jaewoong.lee.jl3663@yale.edu) (J. Lee) . **[Corresponding author. ronald.krauss@ucsf.edu](Corresponding author. ronald.krauss@ucsf.edu) (R.M. Krauss) .  \nAuthor contributions  \nJ.L wrote the first draft of the manuscript. J.L. A.M. M.J.S., and R.M.K. edited and wrote the final version of the manuscript. All authors have read and approved the final manuscript.  \nCRediT authorship contribution statement  \nJaewoong Lee: Writing – review & editing, Writing – original draft, Visualization, Validation, Conceptualization. Arya Mani: Writing – review & editing, Validation. Min-Jeong Shin: Writing – review & editing, Validation. Ronald M. Krauss: Writing – review & editing, Visualization, Validation, Supervision, Conceptualization.  \nDeclaration of Competing Interest  \nThere are no conflicts of interest to be reported that are related to this manuscript.  \nAuthor Manuscript Author Manuscript Author Manuscript Author Manuscript  \nLee et al. Page 2  \nenhance fatty acid-related processes to meet heightened metabolic demands. In obese individuals, the obesity-derived lipids and adipokines surrounding adipocytes rewire lipid metabolism in malignant B cells, evading cytotoxic therapies. Genetic drivers such as MYC translocations also intrinsically alter lipid metabolism in malignant B cells.  \nIn summary, intrinsic and extrinsic factors converge to reprogram lipid metabolism, fostering aggressive phenotypes in B cell malignancies. Therefore, targeting altered lipid metabolism has tran","cbCairCGBkmaVf8L","https://ap.wps.com/l/cbCairCGBkmaVf8L","pdf",1542396,"English","# Abstract\n# Keywords\n# 1. Introduction\n## B cell malignancies and lipid-level metabolic reprogramming\n## BCR signaling, lipid rafts, and lipid kinase regulation\n## MYC-driven lipid uptake and fatty acid oxidation","[{\"question\":\"Why is altered lipid metabolism relevant to B cell malignancies?\",\"answer\":\"Disrupted lipid metabolism contributes to development and progression of B cell malignancies by affecting lipid species that support proliferation and survival pathways.\"},{\"question\":\"How do phospholipids influence malignant transformation in B cell cancers?\",\"answer\":\"Phospholipids participate in initial signaling cascades that enable B cell activation and malignant transformation through constitutive B cell receptor (BCR) signaling.\"},{\"question\":\"What roles do cholesterol and sphingolipids play in oncogenic signaling?\",\"answer\":\"Dysregulated cholesterol and sphingolipid homeostasis support lipid raft integrity, which is crucial for propagating oncogenic signals.\"}]","Leveraging altered lipid metabolism in treating B cell malignancies | PDF",1790021910,126,[146,150,154,158,162],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67ab8a9794ac4e03ba790c17bac4c313.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0129350000949c35170b819892984708.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f970aa6b0b6c0fdc983104423e313b1a.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8f198713c26fff6b73edf9771d655620.webp",980,1268,{"page_no":24,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8ab8575ab29544caa3ecab44d3034fe6.webp",979,1267]